Get the Stockscreener App
3.28
0.61%
-0.02
After Hours:
3.28
Armata Pharmaceuticals Inc stock is traded at $3.28, with a volume of 8,258.
It is down -0.61% in the last 24 hours and up +11.56% over the past month.
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections in the United States. The company develops its products using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. The company is also developing and advancing synthetic phage for treating diseases caused by pseudomonas aeruginosa. Armata Pharmaceuticals, Inc. is headquartered in Marina del Rey, California.
See More
Previous Close:
$3.30
Open:
$3.32
24h Volume:
8,258
Relative Volume:
0.76
Market Cap:
$118.83M
Revenue:
-
Net Income/Loss:
$-41.36M
P/E Ratio:
-2.00
EPS:
-1.64
Net Cash Flow:
$-42.09M
1W Performance:
+4.46%
1M Performance:
+11.56%
6M Performance:
+182.76%
1Y Performance:
+38.98%
1-Day Range:
$3.19
$3.32
1-Week Range:
$3.09
$3.32
52-Week Range:
$0.8981
$3.32
Armata Pharmaceuticals Inc Stock (ARMP) Company Profile
Name
Armata Pharmaceuticals Inc
Sector
Industry
Phone
310-655-2928
Address
4503 Glencoe Avenue, Marina del Rey, CA
Compare ARMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARMP
Armata Pharmaceuticals Inc
|
3.28 | 119.56M | 0 | -41.36M | -42.09M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Armata Pharmaceuticals Inc Stock (ARMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-19-19 | Initiated | Ladenburg Thalmann | Buy |
Armata Pharmaceuticals Inc Stock (ARMP) Latest News
Will Armata Pharmaceuticals Inc. stock deliver consistent dividendsTrade Risk Report & Risk Controlled Daily Plans - newser.com
Trend analysis for Armata Pharmaceuticals Inc. this weekInsider Selling & AI Forecasted Stock Moves - newser.com
Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™ - Stock Titan
Candlestick signals on Armata Pharmaceuticals Inc. stock todayJuly 2025 News Drivers & Risk Managed Investment Strategies - newser.com
Can Armata Pharmaceuticals Inc. stock rebound after recent weaknessFed Meeting & Proven Capital Preservation Methods - newser.com
Armata Pharmaceuticals Inc. stock volume spike explained2025 Trading Recap & Daily Entry Point Trade Alerts - newser.com
Using fundamentals and technicals on Armata Pharmaceuticals Inc.2025 Stock Rankings & Reliable Trade Execution Plans - newser.com
Can Armata Pharmaceuticals Inc. rally from current levelsTrade Volume Summary & Weekly High Momentum Picks - newser.com
Can Armata Pharmaceuticals Inc. stock sustain market leadership2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Real time alert setup for Armata Pharmaceuticals Inc. performancePortfolio Update Summary & Capital Efficiency Focused Strategies - newser.com
Is Armata Pharmaceuticals Inc. stock bottoming out2025 Top Decliners & Safe Capital Growth Tips - newser.com
What momentum shifts mean for Armata Pharmaceuticals Inc.2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
What indicators show strength in Armata Pharmaceuticals Inc.Portfolio Return Summary & Real-Time Buy Signal Alerts - newser.com
What insider purchases suggest about Armata Pharmaceuticals Inc. stock2025 Breakouts & Breakdowns & Verified Entry Point Detection - newser.com
Published on: 2025-10-09 05:27:25 - newser.com
Should you hold or exit Armata Pharmaceuticals Inc. nowWeekly Investment Summary & AI Powered Trade Plan Recommendations - newser.com
Is Armata Pharmaceuticals Inc. stock a buy for dividend growthJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - newser.com
Are Medical Stocks Lagging Armata Pharmaceuticals (ARMP) This Year? - Yahoo Finance
Analyzing Armata Pharmaceuticals Inc. with multi timeframe chartsWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
Why Armata Pharmaceuticals Inc. (TG1N) stock is a strong analyst pickJuly 2025 Selloffs & Technical Entry and Exit Alerts - newser.com
Analyzing Armata Pharmaceuticals Inc. with risk reward ratio chartsProfit Target & Daily Technical Forecast Reports - newser.com
Is Armata Pharmaceuticals Inc. stock supported by strong cash flowsJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
How analysts revise price targets for Armata Pharmaceuticals Inc. stock - newser.com
Armata Pharmaceuticals Inc. stock daily chart insights2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Armata Pharmaceuticals Inc Stock Analysis and ForecastStock Buyback Announcements & Affordable Stock Picks - earlytimes.in
What analysts say about Armata Pharmaceuticals Inc stockShort Selling Opportunities & Invest Like A Pro - earlytimes.in
Armata Pharmaceuticals Inc Stock (ARMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):